Pretreatment HIV Drug Resistance to Integrase Strand Transfer Inhibitors Among Newly Diagnosed HIV Individuals — China, 2018–2023
The current prevalence of PDR to INSTIs in China remains low. However, given the increasingly widespread use of INSTIs, continuous surveillance of drug resistance emergence and transmission patterns is essential.
Authors
- Peixian Xin (ORCID: https://orcid.org/0009-0006-7592-9473)
- Jin Chen (ORCID: https://orcid.org/0000-0002-5557-2079)
- Yuhua Ruan (ORCID: https://orcid.org/0000-0003-2346-9154)
- Hongping Hu (ORCID: https://orcid.org/0000-0001-9708-9141)
- Yi Feng (ORCID: https://orcid.org/0000-0002-3952-1351)
- Huan Li (ORCID: https://orcid.org/0000-0003-0973-9955)
- Qi Li (ORCID: https://orcid.org/0000-0002-4630-3387)
- Dong Wang (ORCID: https://orcid.org/0000-0001-7877-7440)
- Miaomiao Li (ORCID: https://orcid.org/0000-0002-7328-0205)
- Hongli Chen (ORCID: https://orcid.org/0009-0001-6466-1823)
- Xiu Liu (ORCID: https://orcid.org/0009-0005-5721-4100)
- Hui Xing
- Lingjie Liao (ORCID: https://orcid.org/0000-0003-3880-4744)
- Jingjing Hao (ORCID: https://orcid.org/0009-0004-5977-2328)
- Jing Hu (ORCID: https://orcid.org/0009-0008-1144-6995)
- Yantong Li (ORCID: https://orcid.org/0000-0002-7349-1598)
- Chang Song (ORCID: https://orcid.org/0009-0007-5048-6394)
- Jialu Li (ORCID: https://orcid.org/0000-0002-6411-6876)
- Fangyuan Li (ORCID: https://orcid.org/0009-0000-4738-0256)
Institutions
- Chinese Center For Disease Control and Prevention (CN)
Publication Details
- Journal
- China CDC Weekly
- Published
- 2025-01-01
- DOI
- https://doi.org/10.46234/ccdcw2025.007
- Citations
- 3
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Centers for Disease Control and Prevention